- Latest news▼
-
17:25, April 22 Scientists found baked goods and lack of sleep to be more dangerous than alcohol
-
16:02, April 22 342 cases of measles recorded in Armenia so far in 2024
-
15:29, April 22 BrainStimulation: electrical brain stimulation alleviates anxiety and depression in the elderly
-
08:27, April 22 Cognitively stimulating jobs in midlife could lower dementia risk in old age, study finds
-
20:37, April 21 Environmental Health Perspectives: Microplastics ingested with food and water can spread from the gut to the brain
-
22:41, April 20 Scientists develop new method to safely stimulate immune cells to fight cancer
-
20:46, April 20 Blood test can determine who is at risk of developing multiple sclerosis - scientists
-
18:36, April 20 Next pandemic likely to be triggered by flu - scientists
-
12:16, April 19 Scientists grow human mini-lungs in lab
-
10:23, April 19 JAMA Oncology: Urine test can help rule out high-grade prostate cancer with almost 100% accuracy, study shows
-
18:00, April 18 Daily Mail: Elderly woman in China gets infected with brain-eating amoeba
-
14:19, April 18 Obesity: exercising before breakfast helps you lose weight faster
-
10:42, April 18 The Conversation: childhood trauma can cause pathological hoarding
-
08:37, April 18 Daily Mail: Satiating food reduces cravings for sweets, nutritionist says
-
18:22, April 17 First Armenian-German Conference entitled “Heart Failure Spring School”
All materials
New COVID-19 vaccine protects against severe COVID-19
The SARS-CoV-2 vaccine, based on the Ad26 adenovirus, induces a sustained immune response and reliably protects against severe manifestations of COVID-19, such as pneumonia and respiratory failure.
Scientists at Beth Israel Deaconess Medical Center have proven this in preclinical trials, according to a press release on Phys.org
In the study, specialists injected 52 rhesus monkeys with a single dose of a modified adenovirus (Ad26), which expresses an S-protein (spike protein), which plays a key role in the infection of the host cell with coronavirus. After that, the animals were infected with the SARS-CoV-2 through the nose and trachea.
Research has shown that Ad26 induced a sustained neutralizing antibody response and provided complete or nearly complete respiratory protection following coronavirus infection.
The vaccine is currently undergoing clinical trials.
Follow NEWS.am Medicine on Facebook and Twitter
- Video
- Event calendar
- Archive
- Most read
month
week
day
- Daily Mail: intermittent fasting is not suitable for children and women before their periods 1296
- Daily Mail: Elderly woman in China gets infected with brain-eating amoeba 1090
- JAMA Oncology: Urine test can help rule out high-grade prostate cancer with almost 100% accuracy, study shows 1083
- Obesity: exercising before breakfast helps you lose weight faster 1080
- The Conversation: childhood trauma can cause pathological hoarding 1078
- Daily Mail: Satiating food reduces cravings for sweets, nutritionist says 1046
- First Armenian-German Conference entitled “Heart Failure Spring School” 1044
- Why do kids usually recover from COVID-19 more easily than adults? 983
- Scientists grow human mini-lungs in lab 909
- Next pandemic likely to be triggered by flu - scientists 425
- Scientists found baked goods and lack of sleep to be more dangerous than alcohol 380
- Blood test can determine who is at risk of developing multiple sclerosis - scientists 357
- Scientists develop new method to safely stimulate immune cells to fight cancer 338
- Cognitively stimulating jobs in midlife could lower dementia risk in old age, study finds 325
- 342 cases of measles recorded in Armenia so far in 2024 323
- Find us on Facebook
- Poll